Position in REPL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,335
+$401 QoQ
Shares Held
482
-25.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#173
of 199 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hurley Capital, LLC holds $83,925 across 20 Biotechnology names. REPL ranks #8 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
100 | $8,695 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
206 | $7,290 | |
| 3 | SANA |
Sana Biotechnology, Inc.
|
2,000 | $6,980 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
37 | $6,929 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
56 | $6,217 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
149 | $6,053 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
145 | $5,611 | |
| 8 | REPL |
Replimune Group, Inc.
This page
|
482 | $5,335 |
All Filings in REPL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,335 | 482 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,934 | 645 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $4,190 | 1,000 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||